โณ
Showing Q3 2025 data
Qiming U.S. Ventures Management, LLC's Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Qiming U.S. Ventures Management, LLC
โขCIK: 1909617โขFiling: Q3 2025
**Qiming U.S. Ventures Management, LLC** manages $56M across a concentrated portfolio of four positions. The fund exhibits significant conviction in its top holdings, led by a substantial allocation to UBS at $35.5M. Further notable positions include KRRO at $17.6M, alongside smaller, targeted investments in JSPR ($2.2M) and KZR ($0.3M). This structure suggests a focused, high-conviction approach within the U.S. market.
Total AUM
$55.6M
QoQ Performance
+135.6%
Positions
4
Top 10 Concentration
100.0%
Latest Filing
Q3 2025
Top Holdings Allocation
TOUR
KRRO
TOURMALINE63.8%
KRRO31.7%
JSPR4.0%
KZR0.6%
๐ Biggest Buys
No new positions or increases this quarter
๐ Biggest Sells
No reductions this quarter
Sector Breakdown
Other100.0%
๐ช Exited Positionssold since Q2 2025
โ
HILLEVAX INC
SOLD
$741.5K
Historical Filings
Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023